Consulting Firm McKinsey to Pay $230 Million in Latest US Opioid Settlements

Consulting Firm McKinsey to Pay $230 Million in Latest US Opioid Settlements
Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, on April 25, 2017. George Frey/Reuters
Reuters
Updated:
0:00

Consulting firm McKinsey & Co. has agreed to pay $230 million to resolve lawsuits by hundreds of U.S. local governments and school districts alleging it fueled an epidemic of opioid addiction through its work for bankrupt OxyContin maker Purdue Pharma and other drug companies.

The settlements, which require a judge’s approval, were disclosed in papers filed on Tuesday in federal court in San Francisco. The money is on top of the $641.5 million that McKinsey already paid to resolve claims by state attorneys-general.